De-escalating dose intensified anti-TNF in IBD: works with tight monitoring

De-escalating dose intensified anti-TNF therapy is possible in about two thirds of IBD patients, a small Australian study has shown. De-escalation was shown to be feasible and safe in patients who had achieved deep remission, and who underwent tight monitoring, according to Victorian researchers.  The findings, which showed patients were able to maintain reduced dosing ...

Already a member?

Login to keep reading.

© 2021 the limbic